Protalix BioTherapeutics News, Protalix BioTherapeutics Quote, PLX Quote

Protalix BioTherapeutics (NY:PLX) Delayed: 2.62 -0.16 (5.76%)

Prev. Close

$2.78

Today 6M 1Y 5Y

Open

$2.70

52 Wk High

$1.11

52 Wk Low

$0.41

Day High

$2.73

Day Low

$2.59

P/E

N/A

EPS

$-0.29

Volume

883,379

Friends, Peers and Foes (?): PBDA, PBD US74365A30 (more...)

ALERTS | RSS

Mar 4, 2026 04:41 PM Form SCHEDULE 13G Protalix BioTherapeutics Filed by: MAK Capital Fund LP
Feb 11, 2026 05:11 PM Form 8-K Protalix BioTherapeutics For: Feb 11
Jan 30, 2026 10:10 AM Form 8-K Protalix BioTherapeutics For: Jan 30
Jan 30, 2026 09:50 AM Chiesi and Protalix receive EU panel backing for extended Elfabrio dosing
Jan 30, 2026 09:47 AM Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU
Jan 5, 2026 06:56 AM Form 8-K Protalix BioTherapeutics For: Jan 05
Jan 5, 2026 06:50 AM Protalix advances gout treatment PRX-115 into phase 2 trials
Jan 5, 2026 06:50 AM Protalix BioTherapeutics Letter to Stockholders
Dec 23, 2025 07:26 AM Form 4 Protalix BioTherapeutics For: Dec 19 Filed by: Bashan Dror
Dec 17, 2025 06:50 AM Protalix and Secarna partner on rare kidney disease therapies

Entities mentioned with PLX

View All Entities